Najem Dema, Rennie Kerry, Ribecco-Lutkiewicz Maria, Ly Dao, Haukenfrers Julie, Liu Qing, Nzau Munyao, Fraser Douglas D, Bani-Yaghoub Mahmud
a Department of Translational Bioscience, National Research Council Canada, Ottawa, ON K1A 0R6, Canada.
b Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Biochem Cell Biol. 2018 Aug;96(4):391-406. doi: 10.1139/bcb-2016-0160. Epub 2018 Jan 25.
Traumatic brain injury (TBI) is a leading cause of morbidity and mortality worldwide. Due to its high incidence rate and often long-term sequelae, TBI contributes significantly to increasing costs of health care expenditures annually. Unfortunately, advances in the field have been stifled by patient and injury heterogeneity that pose a major challenge in TBI prevention, diagnosis, and treatment. In this review, we briefly discuss the causes of TBI, followed by its prevalence, classification, and pathophysiology. The current imaging detection methods and animal models used to study brain injury are examined. We discuss the potential use of molecular markers in detecting and monitoring the progression of TBI, with particular emphasis on microRNAs as a novel class of molecular modulators of injury and its repair in the neural tissue.
创伤性脑损伤(TBI)是全球发病和死亡的主要原因。由于其高发病率以及常常出现的长期后遗症,TBI每年显著增加了医疗保健支出成本。不幸的是,该领域的进展因患者和损伤的异质性而受到阻碍,这在TBI的预防、诊断和治疗中构成了重大挑战。在本综述中,我们简要讨论TBI的病因,随后阐述其患病率、分类和病理生理学。研究了用于研究脑损伤的当前成像检测方法和动物模型。我们讨论了分子标志物在检测和监测TBI进展中的潜在用途,特别强调了微小RNA作为神经组织损伤及其修复的新型分子调节剂。